Details for Patent: 11,197,830
✉ Email this page to a colleague
Which drugs does patent 11,197,830 protect, and when does it expire?
Patent 11,197,830 protects COMBOGESIC and is included in one NDA.
This patent has forty-two patent family members in thirty-three countries.
Summary for Patent: 11,197,830
| Title: | Pharmaceutical composition containing acetaminophen and ibuprofen |
| Abstract: | Solid oral dosage forms containing 325 mg of acetaminophen and 97.5 mg of ibuprofen or 500 mg of acetaminophen and 150 mg of ibuprofen, wherein the ibuprofen has a [D50] between 1 and 9 μm, are described. |
| Inventor(s): | Maura Murphy, Matt Callahan |
| Assignee: | AFT Pharmaceuticals Ltd |
| Application Number: | US16/287,836 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; |
| Patent landscape, scope, and claims: |
More… ↓ |
Drugs Protected by US Patent 11,197,830
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aft Pharms Us | COMBOGESIC | acetaminophen; ibuprofen | TABLET;ORAL | 209471-001 | Mar 1, 2023 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | A METHOD OF TREATING MILD TO MODERATE ACUTE PAIN IN ADULTS BY ADMINISTERING 975-1000 MG OF ACETAMINOPHEN AND 292.5-300 MG OF IBUPROFEN IN A SINGLE ADMINISTRATION | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,197,830
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2019268077 | ⤷ Start Trial | |||
| Australia | 2021200634 | ⤷ Start Trial | |||
| Australia | 2022201196 | ⤷ Start Trial | |||
| Australia | 2024203208 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
